In the cystoscopic follow-up of non-muscle-invasive transitional cell carcinoma, NMP-22 works for high grades, but unreliable in low grades and upper urinary tract tumors

dc.contributor.author	Coskuner, Enis
dc.contributor.author	Cevik, Ibrahim
dc.contributor.author	Ozkan, Alp
dc.contributor.author	Dillioglugil, Ozdal
dc.contributor.author	Akdas, Atif
dc.date.accessioned	2021-12-21T08:47:23Z
dc.date.available	2021-12-21T08:47:23Z
dc.date.issued	2012
dc.identifier.issn	0301-1623
dc.identifier.uri	https://doi.org/10.1007/s11255-012-0144-x
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2229
dc.description.abstract	Two percent of the bladder non-muscle-invasive (NMI) transitional cell carcinomas (TCC) are associated with upper urinary tract (UUT) TCC. We evaluated the role of nuclear matrix protein-22 (NMP-22) (BladderChek(A (R))) test in the diagnosis of lower urin
dc.language.iso	English
dc.publisher	Sprınger
dc.title	In the cystoscopic follow-up of non-muscle-invasive transitional cell carcinoma, NMP-22 works for high grades, but unreliable in low grades and upper urinary tract tumors
dc.type	Article
dc.relation.journal	Internatıonal Urology And Nephrology
dc.identifier.issue	3
dc.identifier.startpage	793
dc.identifier.endpage	798
dc.identifier.volume	44
dc.identifier.doi	10.1007/s11255-012-0144-x
dc.relation.issue	3
dc.relation.volume	44